Filter
7996
Filtered Results: 7996
Text search:
disease
response
Featured
Recommendations
775
New Publications
1993
Language
Document type
No document type
4200
Studies & Reports
1396
Guidelines
1141
Manuals
399
Strategic & Response Plan
313
Fact sheets
244
Training Material
117
Situation Updates
94
Infographics
28
Resource Platforms
27
Online Courses
27
Brochures
7
Videos
3
Countries / Regions
Global
345
India
322
Kenya
228
Sierra Leone
222
Liberia
202
Ethiopia
157
Nigeria
153
Western and Central Europe
153
South Africa
152
Africa
140
Uganda
126
Latin America and the Carribbean
125
Nepal
115
Congo, Democratic Republic of
102
Bangladesh
101
Syria
99
Rwanda
96
Malawi
94
Tanzania
93
Myanmar / Burma
90
Zambia
89
Guinea
86
Ghana
84
Ukraine
80
Russia
76
South Sudan
74
West and Central Africa
69
Philippines
65
Brazil
64
Middle East and North Africa
64
Eastern Europe
63
East and Southern Africa
61
South–East Asia Region
58
Mozambique
57
Namibia
52
Yemen
52
Indonesia
51
Zimbabwe
50
Asia
50
Senegal
48
Lesotho
43
Cambodia
40
Haiti
37
Germany
36
Eastern Europe and Central Asia
35
Pakistan
30
Botswana
29
Venezuela
27
Burkina Faso
26
Western Pacific Region
24
Mali
23
Cameroon
22
Afghanistan
22
Sudan
21
Eswatini/ Swaziland
20
USA
19
Angola
19
Côte d’Ivoire / Ivory Coast
18
Colombia
18
Somalia
17
Thailand
16
Central African Republic
16
Madagascar
16
China
15
Iraq
12
Jordan
12
Vietnam
12
Lebanon
11
Turkey
11
Peru
11
Guinea-Bissau
10
Benin
10
Tajikistan
10
Ecuador
9
Chile
9
Albania
9
Laos
9
Niger
8
Togo
8
Chad
8
Sri Lanka
8
Moldova
8
Georgia
8
North America
8
Papua New Guinea
7
Argentina
7
Burundi
7
Libya
7
Portugal
7
Paraguay
6
Palestine
6
Southern Africa
6
United Kingdom
6
Gambia
5
North Macedonia
5
Bolivia
5
Mexico
5
Armenia
5
Jamaica
5
Spain
5
Saudi Arabia
4
Egypt
4
Italy
4
Iran
4
Kazakhstan
4
Tunisia
4
Belarus
4
Malaysia
3
Hungary
3
Honduras
3
Greece
3
Bhutan
3
Poland
3
Timor Leste/ East Timor
3
Romania
3
Kyrgyzstan
3
Turkmenistan
3
Japan
3
Mauritius
3
Morocco
2
Mauritania
2
El Salvador
2
Other region
2
Fiji
2
Canada
2
Qatar
2
Bulgaria
2
Estonia
2
Slovakia
2
France
2
Ireland
1
Singapore
1
Dominican Republic
1
Serbia
1
Guatemala
1
Cape Verde
1
Djibouti
1
Mongolia
1
Congo-Brazzaville
1
Lithuania
1
Uzbekistan
1
Gabon
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Algeria
1
Morocco
1
Azerbaijan
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
2879
Clinical Guidelines
620
Public Health
444
Key Resources
324
Women & Child Health
292
Capacity Building
122
Pharmacy & Technologies
85
Annual Report MEDBOX
3
General Guidelines
1
Protection & Security
1
Toolboxes
COVID-19
1185
HIV
628
Mental Health
491
Ebola
427
TB
413
Rapid Response
346
Planetary Health
293
AMR
215
Conflict
202
NTDs
195
Caregiver
187
NCDs
159
Disability
142
Global Health Education
121
Natural Hazards
120
Zika
106
Refugee
103
Pharmacy
95
Cholera
80
Health Financing Toolbox
77
Polio
63
Specific Hazards
59
Social Ethics
24
Typhoon
6
Health Financing
3
South Sudan
2
Following a radiation incident such as an improvised nuclear device (IND) detonation, state and local response authorities will need to establish one or more population monitoring and decontamination facilities to assess
people for radioactive exp...
The Medical Management Guidelines (MMGs) for Acute Chemical Exposures were developed by ATSDR to aid emergency department physicians and other emergency healthcare professionals who manage acute exposures resulting from chemical incidents. The MMGs are intended to aid healthcare professionals involv...
The roundtable provided a forum that allowed communicators across a number of Federal agencies to share information, strategies, and challenges in developing and providing communication messages and materials to the public in preparation for, and in ... to, a radiation emergency. Throughout the discussion , several “big picture” qestions were brought up that may be addressed in future interagency efforts.
ECDC launched the HEPSA (Health Emergency Preparedness Self-Assessment) tool, in order to support countries in improving their level of public health emergency preparedness. The tool is worksheet-based and is targeted at professionals in public health organisations responsible for emergency planning...
Limited coverage of laboratory services and long turnaround times from real-time reverse transcription-polymerase chain reaction (rRT-PCR) for the detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been insufficient to meet the demands in many African countries in ... to the COVID-19 pandemic. Rapid antigen diagnostic tests (AgRDTs) are potentially useful as they can inform healthcare workers and individuals of their infection status at point-of-care testing
Infection prevention and control (IPC) in a CTC/ CTU IPC are all practical measures taken in the healthcare facility to prevent harm caused by infections to patients, health workers and communities.
The main goal of IPC in the cholera response is...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Uni...
The Agency for Toxic Substances and Disease Registry (ATSDR) has produced a three-volume series entitled Managing Hazardous Material Incidents. The series is designed to help emergency response and ...
This document aims to help EU/EEA public health authorities in the tracing and management of persons, including healthcare workers, who had contact with COVID-19 cases. It outlines the key steps of contact tracing, including contact identification, listing and follow-up, in the context of the COVID-...
This guidance will assist staff, students and caregivers in schools (including day care centres, pre-school, primary and secondary schools), higher educational institutions (including universities, research institutes) and other educational institutions with how to address coronavirus ... 2019 (COVID-19) during different outbreak phases as defined in the Africa CDC Stepwise Response.
This document provides guidance to African Union Member States on key mental health and psychosocial support (MHPSS) considerations in relation to the coronavirus disease 2019 (COVID-19) pandemic. It contains useful guidance on MHPSS for the communi...
The first update of the ECDC ventilation guidance document contains:
key new findings that emphasise four bundles of NPIs to reduce the risk of SARS-CoV-2 transmission in closed spaces;
updated references on the evidence of transmission in closed spaces;
recommendations based on the n...
18 Janaury 2021
EU/EEA Member States and the UK have increased their laboratory capacity tremendously over the past 11 months as the majority of the Member States reported sufficient testing capacity until March 2021.
Many countries are adding rapid antigen detection tests (RADT) to their ...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...
Climate change, increasing population densities, and intensified globalisation in trade, travel and migration are among the most important factors shaping the 21st century. Each impacts upon population health and the risk of infectious disease, part...
The Africa Centres for Disease Control and Prevention (Africa CDC) was established in 2017, after the west Africa Ebola virus disease outbreak. Upon creation, the
role of Africa CDC was to mandate ...
The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity syst...
The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity syst...
On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), wh...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like ... occurred in monkeys kept for research. The first human case was recorded in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries.
In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response.
As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa.
